Armata Pharmaceuticals, Inc. (ARMP)
9.54
-0.07
(-0.73%)
USD |
NYAM |
Mar 18, 10:41
Armata Pharmaceuticals Shareholders Equity (Quarterly) : -95.59M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -271.11M |
| Curis, Inc. | -14.69M |
| Plus Therapeutics, Inc. | 3.996M |
| Windtree Therapeutics, Inc. | -11.60M |
| Enzon Pharmaceuticals, Inc. | 42.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.52M |
| Total Liabilities (Quarterly) | 185.10M |
| Debt to Equity Ratio | -1.859 |
| Current Ratio | 0.121 |
| Net Debt Paydown Yield | -5.84% |